1. Home /
  2. Natural Gas

Natural Gas

Jim Cramer Reveals One Part of Schlumberger's Results That 'Freaked People Out'

Schlumberger shares are down 25% since the start of the year.

Gilead Sciences Yescarta Drug Approved By FDA

Shares of Gilead Sciences rose 2% Thursday after the FDA approved its Yescarta lymphoma cancer therapy drug.

Amazon's HQ2, Cancer Therapy Approved: Thursday's Top Stories

Today's Top Stories: Amazon's deadline to submit a proposal to build a new headquarters is today, Gilead shares are jumping as a result of the FDA's approval of a cancer treatment, today marks the 30th anniversary of Black Monday.

Lysol and Clearasil Are Among the Brand You Didn't Know Reckitt Benckiser Owns

The British consumer goods company is behind some of the most well-known brands on your supermarket's shelf including Veet, Lysol and Clearasil.

UnitedHealth and Insurance Agreement Lead Dow, S&P 500 to Records

The Dow ended the day at all-time highs for its second session in a row, though missed out on ending above that 23,000 mark it hit earlier.

Allergan Is the 'Cheapest Big-Cap Drug Stock in the Universe': Cramer

Stockpicker plans to buy more AGN if it drops another $5 or so.

Dow Powers to New Record, Nears 23,000

The Dow, the Nasdaq and the S&P 500 all reached new record highs even though drug stocks were under pressure following comments by President Trump.

President Trump Decides to Cut Off Obamacare Payments to Insurance Companies

"The Department of Health and Human Services has concluded that there is no appropriation for cost-sharing reduction payments to insurance companies under Obamacare"

Video: Jim Cramer on JPMorgan, Citi, Amazon, Micron, Southwest and Domino's

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks.

Pharmacy Is the Next Business Amazon Can Target, Jim Cramer Says

Amazon has its eyes on the pharmacy business. TheStreet's Jim Cramer thinks Amazon can help push for lower prices on prescriptions for consumers.